Pittenger & Anderson Inc’s Actinium Pharmaceuticals ATNM Stock Holding History

Pittenger & Anderson Inc’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$335	Hold	341	–	–	﹤0.01%	500
2026 Q1	$340	Hold	341	–	–	﹤0.01%	510
2025 Q4	$464	Hold	341	–	–	﹤0.01%	497
2025 Q3	$546	Hold	341	–	–	﹤0.01%	439
2025 Q2	$478	Hold	341	–	–	﹤0.01%	412
2025 Q1	$550	Buy	+341	New	+$433	﹤0.01%	410

Other funds holding ATNM

AIS

AM Investment Strategies Chattanooga, Tennessee $521M AUM 33.22% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

AIM

Axiom Investment Management New York $150M AUM

Pittenger & Anderson Inc's ATNM Position: Q2 2026 in Review

Pittenger & Anderson Inc held its Actinium Pharmaceuticals (ATNM) position steady in Q2 2026 at 341 shares worth $335. The position accounts for ﹤0.01% of the portfolio, ranked #500.

Pittenger & Anderson Inc first reported a position in ATNM in Q1 2025 and has held it in 6 quarters since. The position peaked at $550 in Q1 2025. 6 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.

Pittenger & Anderson Inc held 341 shares of Actinium Pharmaceuticals worth $335 as of Q2 2026.
Pittenger & Anderson Inc left its Actinium Pharmaceuticals share count unchanged in Q2 2026.
Actinium Pharmaceuticals made up ﹤0.01% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #500 holding.
Pittenger & Anderson Inc first reported a position in Actinium Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Pittenger & Anderson Inc's Actinium Pharmaceuticals position peaked at $550 in Q1 2025.
6 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.